Blog Read the latest perspectives from our team of subject matter experts and others Smarter Care Navigation: Guiding Patients to the Right Care with AI and DataDespite decades of progress in digitizing healthcare, patient data remains siloed and disconnected, leaving patients to navigate a fragmented and complex system. At the same time, regulatory pressure has… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology Artificial IntelligenceDrug DevelopmentAligning Incentives for Clinical Trials in the Age of AIAt SCOPE Summit US, Ariel Katz, CEO and Co-founder of H1, sat down with Robert Stevens, Head of Clinical Development Procurement at Bristol Myers Squibb, for a candid conversation about… Continue reading → Read the articleno Drug DevelopmentAI in Clinical TrialsAt Fierce JPM Week 2026, Ariel Katz, CEO and Co-founder of H1, sat down with Paul Bridges, PhD, President of Parexel’s Consulting organization, for a fireside chat that cut… Continue reading → Read the articleno Artificial IntelligenceDrug DevelopmentDrug Development Predictions 2026The drug development landscape is undergoing rapid transformation. After a year of significant policy changes, regulatory updates, and technology maturation, 2026 will be a defining year for how clinical… Continue reading → Read the articleno Artificial IntelligenceProvider DataHealthcare Predictions 2026: Market Shifts That Will Define the IndustryFor 2026, we predict four significant developments in healthcare: provider data regulations will require new compliance standards, health plans will make consumer experience a top strategic priority to win new… Continue reading → Read the articleno Drug DevelopmentUnlocking Smarter Clinical Trial Feasibility with Connected DataWhen it comes to clinical trial feasibility, the stakes are high. Choosing the wrong sites or drafting a protocol without full visibility into patient populations can lead to costly… Continue reading → Read the articleno KOL EngagementFrom Fragmented to Connected: Unlocking the Power of 360° HCP EngagementAt Fierce Pharma Week 2025, Stacey Rivkin took the stage to address one of pharma’s most persistent challenges: despite having more data than ever before, medical and commercial teams still… Continue reading → Read the articleno‹12345›»
